DERRICK GROHE: Open Payments
NPI 1811763584 · SANDUSKY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,799 in 99 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $14 · 2025 $1,799
Food & beverage: $1,799
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $674 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $225 |
| Aimmune Therapeutics, Inc. | 9 | $145 |
| Madrigal Pharmaceuticals | 6 | $113 |
| QOL Medical, LLC | 5 | $98 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $73 |
| GENZYME CORPORATION | 3 | $69 |
| Phathom Pharmaceuticals, Inc. | 3 | $61 |
| Janssen Biotech, Inc. | 3 | $59 |
| PFIZER INC. | 2 | $58 |
Products named: RINVOQ, ENTYVIO, SKYRIZI, REZDIFFRA, ZENPEP, MAVYRET, Sucraid, DUPIXENT.
Industry payments across OH — which companies pay providers there.
